Across TCGA pan-cancer cohorts, RN7SKP95 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SKP95’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RN7SKP95 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SKP95 is over-expressed in tumor, although a few such as ESCA show the opposite, repressed pattern.

UCEC, STAD, and BRCA are the cancer types where RN7SKP95 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SKP95 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	II,III,IV	+0.290	.003	6	view →
STAD	All	All	+0.238	.001	4	view →
BRCA	Female	All	+0.163	.037	4	view →
ESCA	Female	All	−0.166	.035	1	view →
LUSC	Female	All	+0.104	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RN7SKP95 RNA expression & survival · all RN7SKP95 data types